Brief: Appili Therapeutics Names Dr. Armand Balboni As Chief Executive Officer
02/12/2019 12:30
Dec 2 (Reuters) - Appili Therapeutics Inc APLI.V :
* APPILI THERAPEUTICS NAMES DR. ARMAND BALBONI AS CHIEF
EXECUTIVE
OFFICER
* SAYS BALBONI WILL REPLACE FORMER CHIEF EXECUTIVE OFFICER
KEVIN
SULLIVAN
* EFFECTIVE TODAY HAS APPOINTED ARMAND BALBONI TO SERVE AS
ITS NEW
CHIEF EXECUTIVE OFFICER
Source text for Eikon: ID:nBw9cPQKfa
Further company coverage: APLI.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Appili Therapeutics
See all newsBrief: Appili Therapeutics Announces Closing Of Second Tranche Of Non-Brokered Private Placement
Brief: Appili Therapeutics Closes First Tranche Of Non-Brokered Private Placement
Brief: Appili Therapeutics Announces Proposed Non-Brokered Private Placement
Brief: Appili Therapeutics Announces Formal Termination Of Arrangement Agreement With Aditxt
Brief: Appili Therapeutics Announces New Patents Granted For Commercial Stage Asset Likmez